Pubblicazioni

  • Giberti C, Gallo F, Francini L, Signori A, Testa M. Musculoskeletal disorders among robotic surgeons: a questionnaire analysis. Arch Ital Urol Androl. 2014 Jun 30;86(2):95-8
  • Giberti C, Gallo F, Schenone M, Cortese P. Simultaneous bilateral robotic partial nephrectomy: Case report and critical evaluation of the technique. World J Clin Cases. 2014 Jun 16;2(6):224-7
  • Gastaldi E, Chiono L, Gallo F, Giberti C. [Prostate brachytherapy: oncological and functional results after 400 cases.] Urologia. 2014 Mar 6;81(Suppl. 23):15-19.
  • Gallo F, Schenone M, Cortese P, Giberti C. [Robotic pyeloplasty: the results after the first 30 patients.] Urologia. 2014 Mar 6;81(Suppl. 23):24-26.
  • Gastaldi E, Gallo F, Chiono L, Giberti C. Salvage low-dose-rate brachytherapy for prostate cancer local recurrence after radical prostatectomy: our first three patients. Urologia. 2014 Jan-Mar;81(1):46-50
  • Giberti C, Gallo F, Cortese P, Schenone M. Combined intravesical sodium hyaluronate/chondroitin sulfate therapy for interstitial cystitis/bladder pain syndrome: a prospective study. Ther Adv Urol. 2013 Aug;5(4):175-9.
  • Giberti C,Gallo F, Schenone M, Cortese P, Ninotta G. Stem Cell Therapy for Male Urinary Incontinence. Urol Int. 2012 Dec 5.
  • Bonamini A, Ninotta G, Gallo F, Gastaldi E, Schenone M, Giberti C, Barile A. [Endoscopic treatment with Wallgraft stenting of complete iatrogenic iliac ureteral injury in a high-risk surgical patient]. Urologia. 2011 Oct;78 Suppl 18:30-4.
  • Gastaldi E, Chiono L, Gallo F, Giberti C. [Prostate I-125 brachytherapy: critical evaluation of mid-term oncologic and functional results in 250 cases]. Urologia. 2011 Apr-Jun;78(2):86-91.
  • Giberti C, Gallo F, Cortese P, Schenone M. The suburethral tension adjustable sling (REMEEX system) in the treatment of female urinary incontinence due to ‘true’ intrinsic sphincter deficiency: results after 5 years of mean follow-up. BJU Int. 2011 Oct;108(7):1140-4.
  • Gallo F, Schenone M, Giberti C. Slings in iatrogenic male incontinence: Current status. Indian J Urol 2010; 26: 279-283.
  • Giberti C, Gallo F, Schenone M, Genova A. Early results of urothelial carcinoma screening in a risk population of coke workers: urothelial carcinoma among coke workers.Biomed Environ Sci 2010; 23:300-304.
  • Gastaldi E, Chiono L, Gallo F, Schenone M, Ninotta G, Chiarlone R, Ghiso G, Giberti C. Dosimetry doesn’t seem to predict the control of organ-confined prostate cancer after I-125 brachytherapy. Evaluation in 150 patients.Arch Ital Urol e Androl 81:4-6; 2009
  • Giberti C, Rosso F. Disfunzioni sessuali femminili. In: Bartolami A. Patologia del pavimento pelvico e stati particolari Pg 70-73, Ed. Elsevier Masson, 2009
  • Giberti C, Gallo F, Schenone M, Cortese P. Robot-assisted laparoscopic pyeloplasty: outcomes reported by a centre with no previous laparoscopic experience. J Robotic Surg 2009 3:83-87.
  • Gallo F, Schenone M, Giberti C. Ureteropelvic junction obstruction: which is the best treatment today? J Laparoendosc Adv Surg Tech A. 2009 Aug 20.
  • Giberti C, Chiono L, Gallo F, Schenone M, Gastaldi E. Radical retropubic prostatectomy versus brachytherapy for low-risk prostatic cancer: a prospective study. World J Urol. 2009 May 20
  • Giberti C, Gallo F, Schenone M, Cortese P, Ninotta G. The bone anchor suburethral synthetic sling for iatrogenic male incontinence: critical evaluation at a mean 3-year followup.J Urol. 2009 May;181(5):2204-8. Epub 2009 Mar 17.
  • Giberti C, Gallo F, Rosignoli MT, Ruggieri A, Barattè S, Picollo R, Dionisio P. Penetration of orally administered prulifloxacin into human prostate tissue.Clin Drug Investig. 2009;29(1):27-34.
  • Giberti C, Siracusano S, Gallo F, Cortese P, Ciciliato S. Transvaginal bone-anchored sling procedure: 4 years of follow-up on more than 200 consecutive patients.Urology. 2008 Jun 11.
  • Gallo F, Gastaldi E, Spirito G, Barile A, Kosir C, Giberti C. A case of iliac-artery-ureteral fistula managed with a combined endoscopic approach.Nat Clin Pract Urol. 2008 Apr;5(4):225-8.
  • Gallo F, Chiono L, Gastaldi E, Venturino E, Giberti C. Prognostic significance of high-grade prostatic intraepithelial neoplasia (HGPIN): risk of prostatic cancer on repeat biopsies.Urology. 2008 Feb 14.
  • Giberti C, Gallo F, Schenone M, Cortese P. The bone-anchor sub-urethral sling for the treatment of iatrogenic male incontinence: subjective and objective assessment after 41 months of mean follow-up.World J Urol. 2007 Nov 3
  • Giberti C, Gallo F, Cortese P, Schenone M. Transobturator tape for treatment of female stress urinary incontinence: objective and subjective results after a mean follow-up of two years.Urology. 2007 Apr;69(4):703-7.
  • Schenone M, Giberti C.Paraurethral leiomyoma. Arch Ital Urol Androl. 2003 Sep;75(3):161-3. Review.
  • Giberti C. Transvaginal sacrospinous colpopexy by palpation-a new minimally invasive procedure using an anchoring system. Urology. 2001 Apr;57(4):666-8; discussion 668-9.
  • Lavagna M, Chiono L, Schenone M, Giberti C. Translabial ultrasonography in the diagnosis of stress urinary incontinence in women. Arch Ital Urol Androl. 2000 Dec;72(4):228-34. Italian.
  • Madjar S, Jacoby K, Giberti C, Wald M, Halachmi S, Issaq E, Moskovitz B, Beyar M, Nativ O (2001) Bone anchored sling for the treatment of post-prostatectomy incontinence. J Urol 165:72-76.
  • Giberti C, Rovida S. Transvaginal bone-anchored synthetic sling for the treatment of stress urinary incontinence: an outcomes analysis. Urology. 2000 Dec 20;56(6):956-61.
  • Giberti C, Schenone M. Giuliani’s method of anterio-lateral transabdominal muscle splitting and nerve preservation for kidney tumors. Prog Urol. 1999 Jun;9(3):562-6. French.
  • Martorana G, Giberti C, Di Silverio F, von Heland M, Rigatti P, Colombo R, Casadei G, Pacifico P.Effects of short-term treatment with the alpha 1-blocker alfuzosin on urodynamic pressure/flow parameters in patients with benign prostatic hyperplasia. Eur Urol. 1997;32(1):47-53.
  • Giberti C, Oneto F, Martorana G, Rovida S, Carmignani G. Radical nephrectomy for renal cell carcinoma: long-term results and prognostic factors on a series of 328 cases. Eur Urol. 1997;31(1):40-8.
  • Giberti C, Martorana G, Carmignani G. The Giuliani muscle splitting and nerve-sparing anterolateral transabdominal approach to the kidney. Urology. 1996 Jun;47(6):911-4.
  • Giberti C, Germinale F, Lillo M, Bottino P, Simonato A, Carmignani G. Obstetric and gynaecological ureteric injuries: treatment and results. Br J Urol. 1996 Jan;77(1):21-6.
  • Giuliani L, Giberti C, Oneto F. Lymph node metastases in renal cell carcinoma. Prog Clin Biol Res. 1992;378:153-60. Review.
  • Giuliani L, Giberti C, Martorana G, Rovida S. Radical extensive surgery for renal cell carcinoma: long-term results and prognostic factors. J Urol. 1990 Mar;143(3):468-73; discussion 473-4.
  • Boccardo F, Decensi A, Guarneri D, Martorana G, Giberti C, Giuliani L. Estramustine phosphate (estracyt) following androgens in men with refractory stage D2 prostate cancer. Cancer Chemother Pharmacol. 1988;22(2):172-4.
  • Giuliani L, Giberti C, Martorana G, Pizzorno R. Lymphadenectomy during radical cystectomy for bladder cancer. Prog Clin Biol Res. 1988;260:329-39. No abstract available
  • Martorana G, Giberti C, Curotto A, Bonamini A, Pizzorno R, Oneto F, Michelotti A, Venturini M, Merlano M, Scarpati D, et al. Alternated pre-cystectomy chemo-radiotherapeutic treatment in patients with locally advanced bladder cancer: a preliminary report. Prog Clin Biol Res. 1988;260:591-8.
  • Boccardo F, Decensi A, Guarneri D, Rubagotti A, Martorana G, Giberti C, Cerruti GB, Tani F, Zanollo A, Germinale T, et al. Long-acting (depot) D-TRP-6 LH-RH (Decapeptyl) in prostate cancer. An Italian multicentric trial.Am J Clin Oncol. 1988;11 Suppl 2:S129-31.
  • Rolandi E, Franceschini R, Giberti C, Brancadoro T, Martorana G, Barreca T. Sustained impairment of pituitary and testicular function in prostatic cancer patients treated with a depot form of a GnRH agonist. Horm Res. 1988;30(1):22-5.
  • Giberti C, Barreca T, Martorana G, Truini M, Franceschini R, Rolandi E, Giuliani L. Hormonal pattern and testicular histology in patients with prostatic cancer after long-term treatment with a gonadotropin-releasing hormone agonist analogue. Eur Urol. 1988;15(1-2):125-7.
  • Martorana G, Giberti C, Pizzorno R, Bonamini A, Oneto F, Curotto A, Soro O. Treatment of urinary tract infections with ciprofloxacin. Clin Ther. 1988;10(5):516-20.
  • Giuliani L, Martorana G, Giberti C, Bonamini A, Pizzorno R, Curotto A. Successful extraction of renal cell carcinoma thrombus extending into the right atrium using extracorporeal circulation, profound hypothermia and cardiac arrest. Eur Urol. 1987;13(1-2):122-4.
  • Giuliani L, Giberti C, Martorana G, Isotta A, Neumaier CE. Value of computerized tomography and ultrasonography in the preoperative diagnosis of renal cell carcinoma extending into the inferior vena cava. Eur Urol. 1987;13(1-2):26-30.
  • Boccardo F, Decensi A, Guarneri D, Rubagotti A, Massa T, Martorana G, Giberti C, Cerruti GB, Tani F, Zanollo A, et al. Long-term results with a long-acting formulation of D-TRP-6 LH-RH in patients with prostate cancer: an Italian prostatic cancer project (P.O.N.CA.P.) study. Prostate. 1987;11(3):243-55.
  • Martorana G, Giberti C, Damonte P, Oneto F, Pizzorno R, Bonamini A, Soro O, Costa A. Treatment of urinary infections in hospitalized urologic patients. Minerva Urol Nefrol. 1986 Oct-Dec;38(4):389-94. Italian.
  • Giuliani L, Giberti C, Martorana G, Rovida S. Surgical management of renal cell carcinoma with vena cava tumor thrombus. Eur Urol. 1986;12(3):145-50.
  • Giuliani L, Barreca T, Giberti C, Franceschini R, Martorana G, Brancadoro MT, Salvemini M, Rolandi E. Treatment of prostatic cancer with a depot form of a luteinizing hormone-releasing hormone analogue. Eur Urol. 1986;12(6):390-4.
  • Barreca T, Martorana G, Franceschini R, Giberti C, Brancadoro MT, Messina V, Rolandi E. Suppression of testicular androgenesis by D-tryptophan-6-luteinizing hormone-releasing hormone does not affect TSH secretion in male subjects. Horm Res. 1986;23(3):181-4.
  • Giuliani L, Giberti C, Martorana G, Bonamini A, Natta GD, Rovida S. Results of radical cystectomy for primary bladder cancer. Retrospective study of more than 200 cases. Urology. 1985 Sep;26(3):243-8.
  • Giuliani L, Martorana G, Giberti C, Damonte P. Extensive lymphadenectomy in renal carcinoma. Rational basis and long-term results. Arch Esp Urol. 1984 Dec;37 Suppl 1:631-7. Spanish.
  • Martorana G, Giberti C, Damonte P. [Preventive treatment of recurrent cystitis in women. Double-blind randomized study using cinoxacin and placebo] Minerva Urol Nefrol. 1984 Jan-Mar;36(1):43-9. Italian.
  • Giuliani L, Martorana G, Giberti C, Pescatore D, Magnani G. Results of radical nephrectomy with extensive lymphadenectomy for renal cell carcinoma. J Urol. 1983 Oct;130(4):664-8.
  • Martorana G, Giberti C, de Ferrari M, Calvi P, Ottaggio L, Pescatore D. Cytogenetic analysis of transitional cell carcinoma of the bladder. Clinical implications. Eur Urol. 1983;9(1):28-31.
  • Martorana G, Giberti C, de Ferrari M, Ottaggio L, Giuliani L. Chromosomal analysis of primary superficial tumors of the bladder. J Urol (Paris). 1983;89(7):489-92. French.
  • Martorana G, Giberti C, Pescatore D, Giuliani L. Preoperative evaluation of adrenal cortical carcinoma extending into the inferior vena cava. J Urol. 1982 Oct;128(4):792-3.
  • Barreca T, Pescatore D, Magnani G, Giberti C, Martorana G, Marabini A, Rolandi E. Long-term treatment with lisuride suppresses prolactin but not thyrotropin secretion. Horm Metab Res. 1982 Sep;14(9):501-2.
  • Martorana G, Giberti C, Pescatore D. Giant echinococcal cyst of the kidney associated with hypertension evaluated by computerized tomography. J Urol. 1981 Jul;126(1):99-100.
  • Giuliani L, Martorana G, Giberti C, Pescatore D. Surgical treatment of renal adenocarcinoma with neoplastic thrombosis of the inferior vena cava. Minerva Chir. 1981 Mar 31;36(6):401-8. Italian.
  • Giuliani L, Pescatore D, Giberti C, Martorana G, Rolandi E, Barreca T, Magnani G. Prolactin secretion in benign prostatic hypertrophy. Eur Urol. 1981;7(5):294-7
  • Rolandi E, Pescatore D, Milesi GM, Giberti C, Sannia A, Barreca T. Evaluation of LH, FSH, TSH, Prl, and GH secretion in patients suffering from prostatic neoplasms. Acta Endocrinol (Copenh). 1980 Sep;95(1):23-6.
  • Giuliani L, Martorana G, Giberti C, Pescatore D. Renal adenocarcinoma with neoplastic thrombus in the inferior vena cava. Prognosis and operative risk. Minerva Chir. 1980 Feb 29;35(4):287-92. Italian.
  • Pescatore D, Giberti C, Martorana G, Natta G, Giuliani L. The effect of cyproterone acetate and orchiectomy on metastases from prostatic cancer. Eur Urol. 1980;6(3):149-53.
  • Giuliani L, Pescatore D, Giberti C, Martorana G, Natta G. Treatment of advanced prostatic carcinoma with cyproterone acetate and orchiectomy-5-year follow-up. Eur Urol. 1980;6(3):145-8.
  • Giuliani L, Martorana G, Giberti C, Pescatore D. Bivalve nephrolithotomy in kidneys with ileal ureter. J Urol. 1979 Dec;122(6):815-6.
  • Giuliani L, Martorana G, Giberti C. The Saralasin test in the diagnosis of renovascular hypertension. Personal experience. Minerva Nefrol. 1979 Oct-Dec;26(4):623-8. Italian.
  • Giuliani L, Pescatore D, Martorana G, Giberti C, Barreca T, Rolandi E. Increased serum prolactin pituitary reserve in patients with prostatic neoplasms. Br J Urol. 1979 Oct;51(5):390-2.
  • Giuliani L, Pescatore D, Giberti C, Martorana G. Usefulness and limitation of estrogen receptor protein (ERP) assay in human renal cell carcinomas. Eur Urol. 1978;4(5):342-7.
  • Giuliani L, Pescatore D, Giberti C. Hormone therapy in renal adenocarcinoma. Minerva Chir. 1977 Dec 15-31;32(23-24):1463-5. Italian.
Edinet - Realizzazione Siti Internet